Proton-pump inhibitor therapy as a risk factor for gastric polyp development: A single center experience in a private hospital

被引：0
|
作者：
Lesmana, Cosmas Rinaldi Adithya
Cahyadinata, Lidwina
Pakasi, Levina S.
Lesmana, Laurentius Adrianto
机构：
[1] Medistra Hosp, Dept Digest Dis, Jakarta, Indonesia
[2] Medistra Hosp, GI Oncol Ctr, Jakarta, Indonesia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷
关键词：
chronic acid suppression therapy; gastric polyp; proton-pump inhibitor; upper GI endoscopy;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OE-0558 (P
引用
收藏
页码：380 / 380
页数：1
相关论文
共 41 条
  • [1] The costly case of proton-pump inhibitors: a single-center experience
    Suresh Kumar, Vishnu Charan
    Patthipatti, Venkata Suresh
    Mani, Kishore Kumar
    Elangovan, Abbinaya
    Goldstein, Lawrence
    [J]. THERAPEUTIC ADVANCES IN GASTROINTESTINAL ENDOSCOPY, 2020, 13
  • [2] Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
    Holmberg, Dag
    Lagergren, Jesper
    [J]. JOURNAL OF GASTROENTEROLOGY, 2023, 58 (02) : 183 - 183
  • [3] Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy
    Waldum, Helge
    [J]. JOURNAL OF GASTROENTEROLOGY, 2023, 58 (02) : 182 - 182
  • [4] Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy
    Helge Waldum
    [J]. Journal of Gastroenterology, 2023, 58 : 182 - 182
  • [5] Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
    Dag Holmberg
    Jesper Lagergren
    [J]. Journal of Gastroenterology, 2023, 58 : 183 - 183
  • [6] Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
    Dag Holmberg
    Fredrik Mattsson
    Shaohua Xie
    Eivind Ness-Jensen
    Hashem El-Serag
    Jesper Lagergren
    [J]. Journal of Gastroenterology, 2022, 57 : 942 - 951
  • [7] Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
    Holmberg, Dag
    Mattsson, Fredrik
    Xie, Shaohua
    Ness-Jensen, Eivind
    El-Serag, Hashem
    Lagergren, Jesper
    [J]. JOURNAL OF GASTROENTEROLOGY, 2022, 57 (12) : 942 - 951
  • [8] Patients at risk for gastrointestinal bleeding infrequently receive proton pump inhibitor therapy at discharge: a single center experience
    Levy, Adam
    Katz, Philip
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S39 - S39
  • [9] Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus
    Hillman, LC
    Chiragakis, L
    Shadbolt, B
    Kaye, GL
    Clarke, AC
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2004, 180 (08) : 387 - 391
  • [10] Proton-pump inhibitor therapy and vitamin B12 status in an inpatient hospital setting
    Hartman, Brenda
    Donnelly-VanderLoo, Mary
    Watson, Tiffany
    O'Connor, Colleen
    Madill, Janet
    [J]. APPLIED PHYSIOLOGY NUTRITION AND METABOLISM, 2016, 41 (10) : 1071 - 1076
12345